Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 8Melanoma 7Colitis, Ulcerative 6Inflammatory Bowel Diseases 5Crohn Disease 5Colitis 4Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 3Urogenital Neoplasms 2Inflammation 2Hematologic Neoplasms 2Graft vs Host Disease 2Fatigue 2Depressive Disorder, Major 2Depression 2Cachexia 2Anorexia 2Vasculitis 1Takayasu Arteritis 1Syndrome 1Stroke 1Stevens-Johnson Syndrome 1Spondylitis, Ankylosing 1Skin Neoplasms 1Recurrence 1Rare Diseases 1Psoriasis 1Precancerous Conditions 1Pemphigoid, Benign Mucous Membrane 1Pancreatic Neoplasms 1

Interventions

Infliximab 1CT-P13 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Takayasu Arteritis × Infliximab × Clear all
NCT02457585 2017-05-15

Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis

Seoul National University Hospital

Phase 2 Unknown
11 enrolled

Takayasu Arteritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡